COVID-19 will likely be with us forever. Here's how we'll live with it. (

As COVID-19 continues to run its course, the likeliest long-term outcome is that the virus SARS-CoV-2 becomes endemic in large swaths of the world, constantly circulating among the human population but causing fewer cases of severe disease. Eventually—years or even decades in the future—COVID-19 could transition into a mild childhood illness, like the four endemic human coronaviruses that contribute to the common cold.

Submitted by Admin on Fri, 01/22/2021 - 20:00

Cancer patients and the COVID-19 vaccines (

The initial batch of COVID-19 vaccines are now available in the U.S. following incredibly fast — “warp speed” — development and testing.

Not so incredibly, there’s a lot of confusion among cancer patients — as well as their oncologists and caregivers — as to whether the vaccine is a good idea or a bad idea for somebody dealing with cancer.

Submitted by Admin on Thu, 01/14/2021 - 19:58

Peer-reviewed report on Moderna COVID-19 vaccine publishes (

The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe COVID-19. Investigators identified no safety concerns and no evidence of vaccine-associated enhanced respiratory disease (VAERD).

Submitted by Admin on Wed, 12/30/2020 - 19:21

FDA authorizes a second vaccine as average daily cases and deaths hit records (

The US Food and Drug Administration on Friday night authorized a second coronavirus vaccine for emergency use as Covid-19 hospitalizations, cases and deaths are piling up in unprecedented ways.

The FDA had signaled it would issue the authorization quickly for Moderna's vaccine candidate, after the agency's vaccine advisers voted Thursday to recommend approval.

Submitted by mo2 on Fri, 12/18/2020 - 19:43

One in 5 COVID-19 patients develop mental illness within 90 days -study (

LONDON, Nov 9 (Reuters) - Many COVID-19 survivors are likely to be at greater risk of developing mental illness, psychiatrists said on Monday, after a large study found 20% of those infected with the coronavirus are diagnosed with a psychiatric disorder within 90 days.

Anxiety, depression and insomnia were most common among recovered COVID-19 patients in the study who developed mental health problems, and the researchers also found significantly higher risks of dementia, a brain impairment condition.

Submitted by Admin on Wed, 11/11/2020 - 18:09

Here's who's on President-elect Biden's newly formed Transition Covid-19 Advisory Board (

(CNN)President-elect Joe Biden and Vice President-elect Kamala Harris' newly appointed Transition Covid-19 Advisory Board is led by established public health officials and staffed by a mix of doctors and current and former government officials, some with high-profile media visibility.

Submitted by Admin on Wed, 11/11/2020 - 18:05

The scientists who developed the Pfizer/BioNTech Covid-19 vaccine are a Turkish-German power couple (

(CNN)Scientists Ugur Sahin and Ozlem Tureci have dedicated their lives to the field of oncology and infectious diseases, and spent years pioneering personalized immunotherapy treatments for cancer.

Submitted by Admin on Tue, 11/10/2020 - 18:16